Tom Handley, MD
Title: Cost-effectiveness of Dapagliflozin for Non-Diabetic Chronic Kidney Disease
Bio: Tom Handley is an MD from the UK. He is a Knight-Hennessy Scholar studying for a master’s degree in Health Policy, with specific interests in transplant policy and optimization.
For dial-in instructions, please contact Ana Mezynski at firstname.lastname@example.org